$CTRP

Secondaries announced 9.6.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Proteostasis Therapeutics Symbol: PTI Price: Last trade $15.24 Trade Date: 9/9 Shares: 4.25 million Underwriter(s)Leerink Partners, RBC Capital Markets, H.C. Wainwright[…]

Secondaries announced 6.11.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Ctrip.com-BLOCK Symbol: CTRP Price: Last trade $77.50 Trade Date: 6/12 Shares: 2 million Underwriter(s) Morgan Stanley Rating=Subscription Needed Company: QLogic Corp.-BLOCK[…]

Secondaries announced 5.11.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Ctrip.com-BLOCK Symbol: CTRP Price: Last trade $63.73 Trade Date: 5/12 Shares: 600,000 Underwriter(s) Morgan Stanley Rating=Subscription Needed Company: Spectrum Brands Symbol:[…]

Scroll to top
error: Content is protected !!